Phibro Animal Health | PAHC - Dochód Netto





Dochód Netto Zmiana Data
Align Technology USD 108.29M 4.48M 2026-06
ANI Pharmaceuticals USD 24.71M 4.78M 2026-06
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Henry Schein USD 94M 13M 2026-06
Idexx Laboratories USD 338.41M 59.97M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Merck USD -1.34B 2.9B 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Pacira USD 4.65M 1.74M 2026-06
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 38.54M 15.39M 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Zoetis USD 691M 90M 2026-06